Expects Q2 Revenue Between $86.2M-$86.3M, Pro-Forma Revenue (including new platform pre-orders) Between $102.4M-$102.5M, Decreases FY 2024 Guidance to $430M-$440M Conference call to be held on Thursday, Aug. 1, 2024, at 8:30 a.m. Eastern Time YOKNEAM, Israel, July 11, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the second quarter of 2024 before the Nasdaq market opens on Thursday, Aug. 1, 2024. InMode is currently finalizing its financial results for the second quarter of 2024. While complete financial information and operating data are not yet available, set forth below are certain preliminary financial results for the period, subject to final adjustments and subject to other developments that may arise between now and the time such financial results are published. As discussed last quarter, InMode recently introduced two new platforms to the market, resulting in a transition phase with pre-orders not fully reflected in the quarterly results. Additionally, macro-economic factors continue to impact the aesthetics industry. Preliminary results suggest that management anticipates the following in the second quarter of 2024: Revenue to be in the range of $86.2 million to $86.3 million Pro-forma revenue (including pre-orders of new platforms not yet delivered) to be in the range of $102.4 million to $102.5 million Non-GAAP1 gross margin to be in the range of 80% to 81% Pro-forma Non-GAAP2 gross margin to be in the range of 82% to 83% Full Year 2024 revenue to be ...